CoreCap Advisors’s Quest Diagnostics DGX Stock Holding History

CoreCap Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$250K	Hold	1,073	–	–	0.01%	772
2026 Q2	$228K	Buy	1,073 +509	+90%	+$100K	0.01%	821
2026 Q1	$111K	Hold	564	–	–	﹤0.01%	991
2025 Q4	$97.9K	Sell	564 -1	-0.2%	-$182	﹤0.01%	1042
2025 Q3	$108K	Buy	565 +326	+136%	+$57.9K	﹤0.01%	1005
2025 Q2	$43K	Sell	239 -69	-22%	-$12K	﹤0.01%	1316
2025 Q1	$52.1K	Buy	308 +77	+33%	+$12.6K	﹤0.01%	1148
2024 Q4	$34.8K	Buy	231 +11	+5%	+$1.71K	﹤0.01%	1327
2024 Q3	$34.1K	Sell	220 -26	-11%	-$3.88K	﹤0.01%	1343
2024 Q2	$33.7K	Sell	246 -10	-4%	-$1.37K	﹤0.01%	760
2024 Q1	$34.1K	Buy	+256	New	+$33.2K	﹤0.01%	1265
2022 Q4	$213K	Buy	+1,362	New	+$196K	0.02%	521
2022 Q3	–	Sell	-3,840	Closed	-$511K	–	897
2022 Q2	$511K	Buy	+3,840	New	+$523K	0.04%	316
2022 Q1	–	Sell	-3,196	Closed	-$553K	–	903
2021 Q4	$553K	Buy	+3,196	New	+$486K	0.04%	341

Other funds holding DGX

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Midwest Trust Overland Park, Kansas $8.99B AUM 21.14% 1-Year Est. Return

CoreCap Advisors's DGX Position: Q3 2026 in Review

CoreCap Advisors held its Quest Diagnostics (DGX) position steady in Q3 2026 at 1,073 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #772.

CoreCap Advisors first reported a position in DGX in Q4 2021 and has held it in 14 quarters since. The position peaked at $553K in Q4 2021. 241 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

CoreCap Advisors held 1,073 shares of Quest Diagnostics worth $250K as of Q3 2026.
CoreCap Advisors left its Quest Diagnostics share count unchanged in Q3 2026.
Quest Diagnostics made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #772 holding.
CoreCap Advisors first reported a position in Quest Diagnostics in Q4 2021 and has held it in 14 quarters since.
CoreCap Advisors's Quest Diagnostics position peaked at $553K in Q4 2021.
241 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.